• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aclarion, Inc. - Warrant (NQ:ACONW)

0.0359 +0.0004 (+1.13%)
Streaming Delayed Price Updated: 3:31 PM EST, Jan 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Aclarion, Inc. - Warrant

News headline image
Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st
November 14, 2024
Via ACCESSWIRE
News headline image
Aclarion to Present at Third Annual Winter Wonderland - Best Ideas Virtual Investor Conference on February 21st - 24th, 2023
February 16, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Aclarion, Inc. Releases Updated Investor Presentation In Connection with Appearance at LD Micro Main Event XV
October 25, 2022
Via ACCESSWIRE
News headline image
Dr. Sigurd Berven to join Aclarion as a Key Opinion Leader Surgeon Advisor
October 24, 2022
Via ACCESSWIRE
News headline image
Aclarion Announces Participation at the NASS 37th Annual Meeting
October 10, 2022
Via ACCESSWIRE
News headline image
John Keller M.D. to Join Aclarion as a Key Opinion Leader Surgeon Advisor
October 03, 2022
Via ACCESSWIRE
News headline image
Nociscan Selected for Inclusion in Pivotal National Institutes of Health (NIH) Study for Low Back Pain
September 19, 2022
Via ACCESSWIRE
News headline image
Aclarion Announces Start of Healthcare Economic Analysis Study to Evaluate Financial Impact of Nociscan
July 20, 2022
Via ACCESSWIRE
News headline image
Aclarion Announces Start of Healthcare Economic Analysis Study to Evaluate Financial Impact of Nociscan
July 20, 2022
Initial findings from the EVAL study are expected to be released in Q4 2022 
From Aclarion Inc.
Via AccessWire
News headline image
Aclarion to Present 2-year Follow Up Data on Pivotal Clinical Trial Linking Nociscan to Better Surgical Outcomes for Discogenic Low Back Pain
June 22, 2022
Superior Clinical Outcomes for NociscanTM Proving to be Durable at Two Years 
From Aclarion Inc.
Via AccessWire
News headline image
Aclarion, Inc. Announces Closing of $9.4 Million Initial Public Offering
April 26, 2022
SAN MATEO, CA / ACCESSWIRE / April 26, 2022 / Aclarion, Inc. ("Aclarion" or the "Company") (NASDAQ:ACON) (NASDAQ:ACONW), a healthcare technology company that leverages Magnetic Resonance Spectroscopy... 
From Aclarion Inc.
Via AccessWire
Topics Artificial Intelligence Regulatory Compliance
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap